These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22398597)

  • 101. Vertex CF data wow Wall Street.
    Nat Biotechnol; 2017 Sep; 35(9):807. PubMed ID: 28898228
    [No Abstract]   [Full Text] [Related]  

  • 102. Cystic Fibrosis Trust's clarification of Cohen and Raftery's article on cystic fibrosis drug development.
    Owen E
    BMJ; 2014 Mar; 348():g1849. PubMed ID: 24603568
    [No Abstract]   [Full Text] [Related]  

  • 103. Settlement reached over medicaid coverage of cystic fibrosis drug: Arkansas federal court case highlights medical necessity, high cost of targeted therapies.
    Am J Med Genet A; 2015 Apr; 167A(4):viii-ix. PubMed ID: 25820402
    [No Abstract]   [Full Text] [Related]  

  • 104. Recent therapeutic breakthroughs in respiratory medicine.
    Molfino NA
    Expert Rev Respir Med; 2013 Aug; 7(4):331-3. PubMed ID: 23964623
    [No Abstract]   [Full Text] [Related]  

  • 105. Game Changers.
    Ulster Med J; 2015 Oct; 84(3):218-9. PubMed ID: 26668427
    [No Abstract]   [Full Text] [Related]  

  • 106. After the Celebrations: Lessons from the New Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy.
    Barry PJ; Jones AM
    Ann Am Thorac Soc; 2019 Feb; 16(2):189-190. PubMed ID: 30707058
    [No Abstract]   [Full Text] [Related]  

  • 107. The organoid architect.
    Sinha G
    Science; 2017 Aug; 357(6353):746-749. PubMed ID: 28839056
    [No Abstract]   [Full Text] [Related]  

  • 108. Ivacaftor: from bench to bedside... and back again.
    Molloy K; McElvaney NG
    Am J Respir Crit Care Med; 2014 Jul; 190(2):128-9. PubMed ID: 25025350
    [No Abstract]   [Full Text] [Related]  

  • 109. Origins of cystic fibrosis lung disease.
    Stoltz DA; Meyerholz DK; Welsh MJ
    N Engl J Med; 2015 Jan; 372(4):351-62. PubMed ID: 25607428
    [No Abstract]   [Full Text] [Related]  

  • 110. 2015 American Thoracic Society International Conference.
    Akkermans R
    Lancet Respir Med; 2015 Jul; 3(7):513-5. PubMed ID: 26025260
    [No Abstract]   [Full Text] [Related]  

  • 111. A new model for drug development using a multi-stakeholder consortium.
    Hall AK
    BMJ; 2014 Mar; 348():g1850. PubMed ID: 24603569
    [No Abstract]   [Full Text] [Related]  

  • 112. Histamine-stimulated Cl- transport in HeLa cells.
    Russell D; McPherson MA; Dormer RL
    Biochem Soc Trans; 1995 Nov; 23(4):553S. PubMed ID: 8654738
    [No Abstract]   [Full Text] [Related]  

  • 113. Mutation-targeted personalised medicine for cystic fibrosis.
    Colombo C
    Lancet Respir Med; 2014 Nov; 2(11):863-865. PubMed ID: 25311996
    [No Abstract]   [Full Text] [Related]  

  • 114. Origins of cystic fibrosis lung disease.
    Munder A; Tümmler B
    N Engl J Med; 2015 Apr; 372(16):1574. PubMed ID: 25875272
    [No Abstract]   [Full Text] [Related]  

  • 115. Origins of cystic fibrosis lung disease.
    Stoltz DA; Meyerholz DK; Welsh MJ
    N Engl J Med; 2015 Apr; 372(16):1574-5. PubMed ID: 25875271
    [No Abstract]   [Full Text] [Related]  

  • 116. The challenges of maintaining momentum in CF drug development and approval - Commentary.
    Flume PA; VanDevanter DR
    J Cyst Fibros; 2017 Mar; 16(2):170-171. PubMed ID: 28179070
    [No Abstract]   [Full Text] [Related]  

  • 117. Mucosal humoral immunity in cystic fibrosis - a tangled web of failed proteostasis, infection and adaptive immunity.
    Moss RB
    EBioMedicine; 2020 Oct; 60():103035. PubMed ID: 32971469
    [No Abstract]   [Full Text] [Related]  

  • 118. Future therapies for cystic fibrosis.
    Wilson C
    Lancet Respir Med; 2022 Aug; 10(8):e75-e76. PubMed ID: 35779568
    [No Abstract]   [Full Text] [Related]  

  • 119. Promising gene therapies pose million-dollar conundrum.
    Check Hayden E
    Nature; 2016 Jun; 534(7607):305-6. PubMed ID: 27306167
    [No Abstract]   [Full Text] [Related]  

  • 120. Getting Near to "Closing the Gap" in the Pediatric Age Group for the First Personalized Treatment of Cystic Fibrosis.
    van Koningsbruggen-Rietschel S
    Am J Respir Crit Care Med; 2021 Mar; 203(5):536-537. PubMed ID: 33113333
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.